Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
192
-
Total 13F shares, excl. options
-
14M
-
Shares change
-
+311K
-
Total reported value, excl. options
-
$375M
-
Value change
-
+$4.16M
-
Put/Call ratio
-
0.25
-
Number of buys
-
76
-
Number of sells
-
-95
-
Price
-
$26.74
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q3 2023
239 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14M shares
of 30.2M outstanding shares and own 46.41% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.61M shares), VANGUARD GROUP INC (1.39M shares), DIMENSIONAL FUND ADVISORS LP (1.3M shares), Divisadero Street Capital Management, LP (860K shares), STATE STREET CORP (772K shares), GEODE CAPITAL MANAGEMENT, LLC (443K shares), Park West Asset Management LLC (345K shares), Invesco Ltd. (313K shares), JPMORGAN CHASE & CO (290K shares), and Nuveen Asset Management, LLC (266K shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.